Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?-Reference-Cited by-同舟云学术

Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?

Published:2019-12-14 Issue:4 Volume:31 Page:655-665
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Tsvetov G.^ORCID,Amitai O.,Shochat T.,Shimon I.,Akirov A.,Diker-Cohen T.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-019-05261-7.pdf

Reference43 articles.

1. Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) FREEDOM trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765. https://doi.org/10.1056/NEJMoa0809493

2. Baron R, Ferrari S, Russell RGG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48:677–692. https://doi.org/10.1016/j.bone.2010.11.020

3. Drugs@FDA: FDA approved drug products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=125320. Accessed September 23, 2018

4. Block GA, Bone HG, Fang L, Lee E, Padhi D (2012) A single-dose study of denosumab in patients with various degrees of renal impairment. J Bone Miner Res 27:1471–1479. https://doi.org/10.1002/jbmr.1613

5. Jamal SA, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD (2011) Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 26:1829–1835. https://doi.org/10.1002/jbmr.403

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and predictors of hypocalcemia in end-stage renal disease patients on denosumab therapy: A systematic review and meta-analysis;World Journal of Meta-Analysis;2024-09-18

2. Additional effects of herbal medicine combined with bisphosphonates for primary osteoporosis: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-09-13

3. The use of denosumab in osteoporosis – an update on efficacy and drug safety;Expert Opinion on Drug Safety;2024-09-11

4. External Validation and Update of the Risk Prediction Model for Denosumab-Induced Hypocalcemia Developed From a Hospital-Based Administrative Database;JCO Clinical Cancer Informatics;2024-07

5. Nebenwirkungen einer medikamentösen Osteoporosetherapie und Konsequenzen für die Sequenztherapie: Fokus Arzt-Patient Kommunikation;Osteologie;2024-05